A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

C Ballard, A Thomas, S Gerry, L-M Yu, D Aarsland, C Merritt, A Corbett, C Davison, N Sharma, Z Khan, B Creese, P Loughlin, C Bannister, A Burns, S N Win, Z Walker, N Ferreira, P Koranteng, R Vanderputt, M AkinolaL Martos, J Adams, C Dransfield, M Pavey, N Collicott, C Hall, L Rigby, L D Warr, M Leontis, S Shora, S Bhan-Kotwal

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)316-322
    Number of pages7
    JournalJournal of the American Medical Directors Association
    Volume16
    Issue number4
    DOIs
    Publication statusPublished - 2015

    Keywords

    • Alzheimer
    • antipsychotic
    • dementia
    • memantine
    • neuropsychiatric
    • withdrawal

    Cite this